MedPath

The efficiency of nanobubble therapy for oral mucositis during chemotherapy for the patients of advanced gastrointestinal cancer

Not Applicable
Conditions
oral mucositis during chemotherapy
Registration Number
JPRN-UMIN000030385
Lead Sponsor
Fujita Health University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who already have a oral mucositis at the beginning of the study, Patients with underlying diseases associated with oral mucositis such as collagen disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of oral mucositis with grade 2 or more according to CTCAEv 4.0 grade and patient questionnaire
Secondary Outcome Measures
NameTimeMethod
Side effects, The most severe grade of oral mucositis, Period of disappearance of oral mucositis, Adverse events
© Copyright 2025. All Rights Reserved by MedPath